SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-036364
Filing Date
2023-10-05
Accepted
2023-10-05 16:28:36
Documents
16
Period of Report
2023-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46182
2 ex10-1.htm EX-10.1 332246
3 ex10-2.htm EX-10.2 57610
4 ex10-3.htm EX-10.3 20880
5 ex10-1_001.jpg GRAPHIC 72490
  Complete submission text file 0001493152-23-036364.txt   807779

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE invo-20230929.xsd EX-101.SCH 3033
7 XBRL LABEL FILE invo-20230929_lab.xml EX-101.LAB 34916
8 XBRL PRESENTATION FILE invo-20230929_pre.xml EX-101.PRE 22801
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3355
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 231311694
SIC: 3841 Surgical & Medical Instruments & Apparatus